ATB Therapeutics

ATB Therapeutics is a pioneering biopharmaceutical company building a pipeline of antibody–toxin-bioengineered ‘atbodies’.

Atbodies are a novel antibody-based therapy designed to optimize the therapeutic window relative to previous approaches in the field, with the potential to provide clinically superior products for hematological malignancies and solid tumors. Their composition aims to generate increased potency, stability and targeted exposure.